HCV Coinfection Clinical Trial
Official title:
Effect of Daclatasvir Plus Sofosbuvir on Angiogenesis in Egyptian Patients With Chronic HCV Infection
The study aimed at study of the Effect of Daclatasvir Plus Sofosbuvir on Angiogenesis in Egyptian Patients With Chronic HCV Infection
| Status | Recruiting |
| Enrollment | 40 |
| Est. completion date | December 2025 |
| Est. primary completion date | August 2025 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 65 Years |
| Eligibility |
Inclusion Criteria: - Chronic HCV patients Exclusion Criteria: - HCC. - HIV or HBV. - Malignancy. - Pregnancy. |
| Country | Name | City | State |
|---|---|---|---|
| Egypt | Sherief Abd-Elsalam | Tanta |
| Lead Sponsor | Collaborator |
|---|---|
| Sherief Abd-Elsalam |
Egypt,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Number of patients with change in VEGF, TGFB1 | Number of patients with change in VEGF, TGFB1 | 6 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02810275 -
Folinic Acid: Supplementation and Therapy
|
Phase 3 | |
| Completed |
NCT03145753 -
Education vs Education Plus Intervention in HIV/HCV Diagnosis (DRIVE 03)
|
N/A | |
| Completed |
NCT01557998 -
Testing and Linkage to Care for Injecting Drug Users in Kenya
|
N/A | |
| Completed |
NCT01335529 -
Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin
|
Phase 2 | |
| Completed |
NCT03499639 -
Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney Disease
|
Phase 4 | |
| Completed |
NCT01222611 -
HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir
|
Phase 4 | |
| Completed |
NCT03050905 -
Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B
|
Phase 4 | |
| Completed |
NCT02505243 -
Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA Regimens
|
||
| Recruiting |
NCT02086708 -
Ultrasound Method to Measure Fibrosis of the Liver in Children
|
N/A | |
| Completed |
NCT03508115 -
Changes in Cognition in HCV Patients After Virus Eradication With Direct Antiviral Agents
|
||
| Completed |
NCT03214679 -
Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID)
|
N/A | |
| Completed |
NCT02938013 -
deLIVER: Direct Acting Antiviral Effects on the Liver
|
Phase 4 | |
| Completed |
NCT03549832 -
Comparative Study of Two Regiemns in Management of Sofosbuvir/Daclatasvir Failure
|
N/A | |
| Completed |
NCT01900015 -
Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection
|
Phase 4 | |
| Active, not recruiting |
NCT01529073 -
Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection
|
Phase 2 | |
| Recruiting |
NCT01747772 -
Sonoelastography: Ultrasound Method to Measure Liver Fibrosis
|
N/A | |
| Completed |
NCT02693847 -
Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected Patients
|
||
| Recruiting |
NCT03549312 -
Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy
|
Phase 4 | |
| Completed |
NCT03252483 -
Integrating HIV and Hepatitis C Screening in an Urban Emergency Department
|
N/A | |
| Completed |
NCT01335230 -
The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients
|
N/A |